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FOXC2 Is a Winged Helix Gene that Counteracts
Obesity, Hypertriglyceridemia,
and Diet-Induced Insulin Resistance
ide stores (e.g., insulin) which has the potential of coun-
teracting the initial benefits of such treatments, since
more and larger adipocytes will increase insulin resis-
tance (Abbott and Foley, 1987). An ideal therapy should
not only increase insulin sensitivity but also provide
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Several studies using genetically modified mice have
made valuable contributions to our understanding ofSummary
adipocyte metabolism, obesity, and insulin resistance.
Most of these mice have specific and well-defined alter-Obesity, hyperlipidemia, and insulin resistance are
common forerunners of type 2 diabetes mellitus. We ations in adipocyte function affecting insulin action
(Shepherd et al., 1993), differentiation (Moitra et al.,have identified the human winged helix/forkhead tran-
scription factor gene FOXC2 as a key regulator of adi- 1998; Shimomura et al., 1998), metabolism (Osuga et
al., 2000), sensitivity to adrenergic stimuli (Susulic et al.,pocyte metabolism. Increased FOXC2 expression, in
adipocytes, has a pleiotropic effect on gene expres- 1995), or intracellular signaling pathways (Cummings et
al., 1996). We show that in mice overexpressing FOXC2,sion, which leads to a lean and insulin sensitive pheno-
type. FOXC2 affects adipocyte metabolism by increas- in WAT and BAT, the intraabdominal WAT depot is re-
duced and has acquired a brown fat-like histologying the sensitivity of the -adrenergic-cAMP-protein
kinase A (PKA) signaling pathway through alteration whereas interscapular BAT is hypertrophic. Increased
FOXC2 expression has a pleiotropic effect on gene ex-of adipocyte PKA holoenzyme composition. Increased
FOXC2 levels, induced by high fat diet, seem to coun- pression in BAT and WAT. There is an induction of the
BAT-specific gene ucp1 in the intraabdominal WAT de-teract most of the symptoms associated with obesity,
including hypertriglyceridemia and diet-induced insu- pot. We also demonstrate a change in steady-state lev-
els of several WAT and BAT derived mRNAs, encodinglin resistance—a likely consequence hereof would be
protection against type 2 diabetes. genes of importance for adipocyte: (1) insulin action, (2)
differentiation, (3) metabolism, (4) sensitivity to adrener-
gic stimuli, and (5) intracellular signaling. The nature ofIntroduction
these FOXC2-generated responses is consistent with
protection against obesity and related symptoms suchHigh calorie diet and low physical activity are important
etiological factors for type 2 diabetes (also known as as diet induced insulin resistance. Furthermore, in wt
(wild-type) mice, we demonstrate that Foxc2 mRNA lev-noninsulin dependent diabetes mellitus, NIDDM). The
majority of such patients are obese. It has been pre- els are upregulated by high fat diet and that mice with
targeted disruption of one Foxc2 allele have a decreaseddicted that by the year 2020, some 250 million people
world-wide will suffer from type 2 diabetes. Since this interscapular BAT cell mass. These observations sup-
port the view of Foxc2 as an important regulator ofdisease is a major risk factor for ischemic heart disease
and a common cause to renal failure, midlife blindness, adipocyte metabolism with the ability to alter metabolic
efficiency in response to dietary changes.and lower extremity amputations, this threatening epi-
demic will have profound public health implications
(O’Rahilly, 1997; Zimmet and Alberti, 1997). One major Results
problem in the treatment of type 2 diabetes is to increase
insulin sensitivity without promoting adipocyte differen- FOXC2 Is Expressed in WAT and BAT
tiation (e.g., thiazolidindiones) and/or enlarge triglycer- during Postnatal Life
We have provided evidence for the existence of a
winged helix/forkhead gene expressed in adipocytes5Correspondence: sven.enerback@medgen.gu.se
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growth hormone does not appear to regulate Foxc2 (Fig-
ure 1d). The fact that two major regulators of glucose/
adipocyte metabolism—insulin and TNF—regulate
Foxc2 in vitro made us interested in the role of Foxc2
in vivo.
FOXC2 Regulates Adipose Tissue Distribution
and Morphology
We made a DNA construct in which the adipose-specific
aP2 (Coe et al., 1999) enhancer/promoter, known to pro-
mote transcription in BAT and WAT in vivo (Ross et al.,
1990), was fused to a cDNA encoding FOXC2. Mice
transgenic for this construct appear normal in terms of
general behavior and reproduction. Tg (transgenic) mice
have distinctly enlarged bilobed interscapular BAT de-
pots (Figures 2a and 2b), whereas the intraabdominal
WAT depot is clearly reduced (Figures 2c and 2d). Analy-
ses were performed on FOXC2 tg-A mice with wt lit-
termates as controls, mice were approximately 4–6
months of age and fed ad libitum. The intraabdominal
WAT from tg mice has a brownish color, in contrast to
the corresponding WAT in non-tg animals, which is light
Figure 1. Northern Blot Analysis yellow (Figures 2e and 2f). Histological examination of
Adult human tissues (a) and wt adult mouse tissues (b). The blots these fat depots demonstrates an increased size of the
were analyzed with probes specific (with no cross-reactivity) for lipid droplets in BAT from tg mice (Figures 2g and 2h).
FOXC2 (human) and Foxc2 (mouse), respectively. The experiments
The intraabdominal WAT in tg animals has a clearly re-were carried out with 20 g of total RNA/lane using -actin as an
duced cell size and regions of small cells with multilocu-internal control. Mouse adipose tissue (c) was treated with collage-
lar fat droplets (Figures 2i and 2j). In a cold adaptationnase (see under “Experimental Procedures”); RNA from the adipo-
cyte fraction (Adip F) and the stroma/vascular fraction (SV F) were experiment (4C, 24 hr), tg mice display a clear reduction
used and probed for Foxc2, LPL (adipocyte marker), and GAPDH in size and number of triglyceride droplets in BAT (Fig-
(control). In (d), differentiated murine adipocytes (3T3-L1) were stim- ures 2k–2n). This indicates that changes in gene expres-
ulated for 2 hr with insulin (10 g/ml), TNF (50 ng/ml), growth
sion, induced by the transgene, will allow a net accumu-hormone (GH;100 ng/ml) or left untreated (Basal). Northern blot anal-
lation of triglyceride at room temperature (22C),ysis was performed and the Foxc2 mRNA signal was assessed by
whereas these triglycerides are metabolized at 4C.-scintillation counting in a dot-matrix -counter. Image shows
counts over the filter plotted in gray-scale intensity. Bars above the We selected three independent founder lines, tg-A,
Northern blot represent actual cpm over mean cpm of controls tg-B, and tg-C with tg-A having the highest, tg-B the
subtracted of background cpm given as “fold induction.” lowest, and tg-C an intermediate level of FOXC2 expres-
sion in WAT (Figure 4a). There is a dose-response rela-
tion between the expression level of the transgene and(Enerback et al., 1992). To find this gene, we screened a
reduction in the relative weight of the intraabdominalhuman adipocyte cDNA library; two overlapping clones
WAT depot (Figure 3a). A similar dose-response existsrepresenting the human homolog of the mouse gene
for the weight ratios of intraabdominal WAT to interscap-Foxc2 were isolated. Mice lacking Foxc2 have cranofa-
ular BAT (Figure 3b). The relative weight of the interscap-cial, vertebral, and aortic arch malformations. Since
ular BAT depot is increased in tg animals but does notsuch mice die embryonically or perinatally (Iida et al.,
exhibit any dose-response pattern (Figure 3a), which is1997; Winnier et al., 1997), little is known about the
in accordance with the fact that there is no differencefunction of Foxc2 during postnatal life. Northern blot
between tg-A, tg-B, and tg-C in expression of the trans-with mRNA from Homo (Figure 1a), shows that FOXC2
gene in BAT (Figure 4a). Livers from wt and tg-A miceis exclusively expressed in WAT. This human gene is
appear normal in terms of gross morphology, weight,also known as MFH1 (mesenchyme forkhead-1) or
and lipid content (not shown).FKHL14; the mouse homolog is known as Foxc2 or mfh1.
In this paper, we follow a recently adopted nomenclature
and use the gene names FOXC2 and Foxc2 to designate Increased FOXC2 Expression Has a Pleiotropic
Effect on Gene Expressionthe human and mouse genes, respectively. Using mouse
mRNA, we demonstrate expression of Foxc2 in both Steady-state levels of 21 different mRNAs were exam-
ined in WAT and BAT (Figure 4b). Interestingly, there isWAT and BAT (Figure 1b). A more sensitive assay for
transcript detection, such as RT-PCR, shows low levels a dose-dependent induction of the BAT-specific marker
gene ucp1 in WAT (Figure 4b). The tg line with the highestof Foxc2 mRNA in striated muscle from adult mice (not
shown). In a Northern blot experiment using RNA from level of FOXC2 expression (tg-A) has the most prominent
ucp1 induction (Figure 4b). The expression of ucp2 iscollagenase prepared adipocytes, we could demon-
strate that Foxc2 expression is highest in the adipocyte reciprocally regulated as compared with ucp1, and this
type of regulation has previously been reported in micefraction with a lower level of expression in stroma/vascu-
lar cells (Figure 1c). When adipocytes are treated with lacking ucp1 (Enerback et al., 1997). Genes associated
with mitochondrial function and biogenesis such asinsulin or TNF, Foxc2 mRNA levels increase, whereas
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coxII (cytochrome c-oxidase subunit II), encoded by the
mitochondrial genome, and pgc1 (PPAR coactivator-1)
(Wu et al., 1999a) are upregulated in WAT (Figure 4b).
The induction of ucp1 in WAT and the altered WAT
morphology (Figures 2i and 2j) indicates a transition
toward BAT-like properties of the intraabdominal WAT
depot. mRNA levels for 1-3-AR (1-3-adrenergic recep-
tors) are all upregulated in WAT. The most prominent
induction is in mRNA levels for 3-AR in WAT. This is
indicative of increased sensitivity to adrenergic stimuli.
Transcription factors known to promote adipocyte dif-
ferentiation such as C/EBP (CCAAT-box enhancer
binding protein-) (Lin and Lane, 1994), PPAR (peroxi-
some proliferator-activated receptor-) (Tontonoz et al.,
1994), and ADD1/SREBP1 (adipocyte determination and
differentiation-dependent factor-1/sterol regulatory ele-
ment binding protein-1) (Kim and Spiegelman, 1996) are
upregulated in tg WAT (Figure 4b). Even though the WAT
depot is decreased in size in tg animals, the adipocyte
differentiation per se appears to be stimulated. Both
aP2 (Coe et al., 1999) and adipsin (Murray et al., 1999)
are upregulated (Figure 4b). Adipsin is induced in both
WAT and BAT in a dose-dependent manner in relation
to transgene expression. The level of LPL (lipoprotein
lipase) mRNA is only slightly upregulated, whereas the
intracellular and PKA phosphorylation activated lipase—
HSL (hormone sensitive lipase)—is clearly induced in
WAT. Leptin mRNA levels are reciprocally downregu-
lated in relation to expression levels of the transgene
and, in tg BAT, no leptin mRNA can be identified (Figure
4b). mRNA levels of four genes, representing the insulin
pathway, are induced: IR (the insulin receptor), IRS1,
IRS2 (insulin receptor substrate-1 and -2), and GLUT4
(insulin-responsive glucose transporter-4). This is con-
sistent with an increased insulin sensitivity and triglycer-
ide synthesis in adipocytes. The induced level of HSL
mRNA together with increased sensitivity to -adrener-
gic stimuli is compatible with an increased intracellular
capability to induce and maintain lipolysis. This process
can provide FFA as a source of energy for ucp1-induced
heat production. Upregulation of PPAR (peroxisome
proliferator-activated receptor-) in WAT (Figure 4b)
suggests an increase in fatty acid -oxidation. This is
consistent with low levels of FFA and a lean phenotype
(Figures 2 and 3).
FOXC2 Regulates Body Composition, Serum
Lipids, and Insulin Sensitivity
There is a decrease from 30% total lipids in carcasses
of wt mice as compared with 10% in tg mice (p  0.001;
Figure 3c). A significant reduction in serum triglyceride
levels of 57% (p 0.004; Figure 3d) is observed, whereas
no significant change in serum cholesterol can be de-
tected (Figure 3e). FFAs are lowered from 0.92 meq/l to
0.63 meq/l in tg animals (p  0.02; Figure 3f). Plasma
Figure 2. Morphology and Histology of WAT and BAT from Wild-
type (a, c, e, g, i, k, and m) and FOXC2 tg-A (b, d, f, h, j, l, and n)
An exposed dorsal view of the bilobed interscapular brown fat (white (h) mouse. Sections from intraabdominal WAT depots in wt (i) and
arrows) (a and b). A ventral view of the intraabdominal white fat tg (j) mouse. In a cold adaptation experiment, mice were kept at
pads (white arrows) in tg (d) and wt (c) mouse. A comparison of either room temperature (RT) or at 4C for 24 hr, sections from wt
interscapular brown fat pads and intraabdominal white fat pads ([k], RT; [m], 4C) and tg ([l], RT; [n], 4C) BAT. Scale bar for (a)–(d),
from wt (e) and tg (f) mice. BAT at the top and WAT at the bottom. depicted in (c) equals 5 mm, scale bar for (e) and (f), depicted in (e)
Histological sections of interscapular brown fat from wt (g) and tg equals 5 mm, scale bar for (g)–(n), depicted in (m) equals 100 m.
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glucose is down by 10% (p0.01; Figure 3g) and plasma
insulin levels are reduced by 43% (p  0.001; Figure
3h). In tg mice, on a high fat diet, the weight gain is
28% lower (p  0.01; Figure 3m) as compared with wt.
Although lipid content in tg and wt mice are increased
after a high fat diet, tg mice still resist lipid accumulation
to the same degree as is the case for wt littermates—a
49% decrease in tg mice as compared with wt (p 
0.0001; Figure 3n). On a standard diet (4.0% fat), tg and
wt mice display no signs of differences in metabolic
efficiency as judged by the ratio between weight gain
and weight of food eaten (Figure 3o). They do, however,
display a different body composition (Figure 3c). When
fed a high fat diet (35.9% fat), tg mice appear less effi-
cient in their metabolism, since they need to eat more
for each gram of increase in body weight (a reduction
of 30%, p  0.01; Figure 3o). We would like to point out
that the amount of food eaten, both on a standard and
high fat diet, is the same for tg and wt mice. Thus, the
difference seen on a high fat diet is derived from a less
efficient metabolism in tg mice—not allowing triglycer-
ides to accumulate to the same extent as in wt lit-
termates. This is reflected by a decreased weight gain
for mice on a high fat diet (Figure 3o), and a leaner body
composition in tg mice regardless of type of diet (Figures
3c and 3n). These findings are interesting since they
suggest that metabolic efficiency in FOXC2 tg mice can
be regulated in response to food composition. There
are no significant differences in serum glucagon levels,
nor have we observed any significant gender differ-
ences.
In an intravenous glucose tolerance test, plasma glu-
cose for tg mice on standard diet is significantly lower
at 0, 20, and 75 min (p  0.05), and at 50 min (p  0.02;
Figure 3i). The insulin curve exhibits lower insulin levels
for tg mice (Figure 3j) at 0 min (p  0.02), at 1, 5, and
20 min (p  0.05), and at 50 and 75 min (p  0.001). On
high fat diet, the difference is much more pronounced
(Figures 3k and 3l). Glucose levels are lower in tg mice
Analyses were performed on FOXC2 tg-A mice with wt littermates
as controls, mice were approximately 4–6 months of age and fed
adlibitum, if not otherwise indicated, n  4 for each group, and
values are means  SEM. (c) Total body lipid content was analyzed
as total lipid content of carcasses (see under “Experimental Proce-
dures”). (d) Serum triglyceride. (e) Serum cholesterol. (f) Plasma free
fatty acids (FFA). (g) Nonfasting plasma glucose. n  20 in each
group. (h) Plasma insulin. Analysis was performed on the same
animals as in (g). Intravenous glucose tolerance test. Wt and FOXC2
tg-A mice were fed a standrad (i and j) or high fat (k and l) diet
for 14 weeks (for details, see “Experimental Procedures”). After
intravenous (iv) injection of glucose (1 g/kg), blood samples were
drawn immediately before and at 1, 5, 20, 50, and 75 min for analysis
of glucose and insulin. Plasma glucose levels from wt and tg mice
both on a standard i (tg, n  8; wt, n  9) and high fat diet k (tg,
n  5; wt, n  6). Plasma insulin from wt and tg mice both on a
standard diet (j) and a high fat diet (l). Diet-induced weight gains
(high fat diet) in FOXC2 tg (n  7) mice as compared with wt (n 
9; [m]). Body lipid content after a high fat diet (tg, n  6; wt, n  4)
Figure 3. Weight Comparison of BAT and WAT Depots in (n). The weight gain to grams of food eaten ratio was calculated
In (a), weights of intraabdominal WAT and interscapular BAT depots for wt (n  10) and tg (n  9) mice on a standard (St) diet as well
from tg mice (founder lines A, B, and C) are compared to that of wt as for mice on a high fat (Hf) diet (tg, n  7; wt, n  9) (o). No gender
mice. Ratios between weights of intraabdominal WAT to interscapu- differences were observed. For details concerning the diets and
lar BAT for wt and tg founder lines A, B, and C (b). Values are means magnitude of changes observed see “Experimental Procedures”
SEM, n  4 in each group. Metabolic profile, on standard diet (c–h). and corresponding text sections.
FOXC2, a Winged Helix Gene that Counteracts Obesity
567
More Mitochondria and Higher Oxygen
Consumption in WAT from FOXC2 tg Mice
It appears that WAT with an increased expression of
FOXC2 is less efficient in storing triglycerides as com-
pared with wt WAT (Figures 2, 3a, and 3b). This could
be due to an elevated metabolism that would dissipate
energy through induction of ucp1 rather than storing it
as triglycerides. The induction of PGC-1, PPAR, and
coxII (Figure 4b), genes known to be associated with a
stimulated mitochondrial function and biogenesis,
urged us to exploit this possibility. Scanning electron
microscopy shows a clear reduction in size of adipo-
cytes from tg-A as compared with wild-type adipocytes
(43%, p  0.001; Figures 5a, 5b, and 5e). This is in
agreement with the tissue sections in Figures 2i and 2j.
Transmission electron microscopy reveals an increased
amount and size of mitochondria in adipocytes of tg
origin (Figures 5c and 5d). The morphology suggests
that transgenic WAT could indeed function as a dissi-
pater of excess energy. We measured oxygen consump-
tion in isolated pieces of adipose tissue from tg-A and
wt mice; there is almost a 4-fold increase (p  0.001) in
oxygen consumption in tg WAT (Figure 5f). There is no
significant difference in oxygen consumption in BAT.
To study the regulation of Foxc2 in wt mice, we set
up a real-time quantitative PCR assay. As can be de-
duced from Figure 5g, steady-state levels of Foxc2
mRNA in WAT of wt mice on a standard diet (S	/	) is
set to 100% and a decrease of 55% (p 0.066) is noted
in S	/
 mice. An increase of 118% (p0.05) is seen in
wt mice on a high fat diet. Since 
/
 mice have a lethal
phenotype, we compared interscapular BAT cell mass
Figure 4. Northern Blot Analysis of mRNA Derived from WAT and between wt and	/
mice and found a significant reduc-
BAT of wt and FOXC2 tg Mice (Founder Lines A, B, and C)
tion of BAT cell mass in 	/
 mice (p  0.02; Figure 5h).
(a) Expression levels of the FOXC2 transgene in WAT and BAT of This finding demonstrates a gene dose effect on BATwt and tg mice. Note that the human FOXC2 probe is speific for the
cell mass with regard to Foxc2, which strengthens themRNA encoded by the human gene and does not cross-react with
correlation between Foxc2 expression and fat cell massthe murine counterpart Foxc2. Twelve micrograms of total RNA/
lane, GAPDH as an internal control. (b) Relative steady-state mRNA (Figures 3a and 3b). Wt mice on a high fat diet signifi-
levels in WAT and BAT of wt and tg mice (founder lines A, B, and cantly induce their steady-state levels of Foxc2 mRNA
C). For each probe, the exposure time is the same for WAT and BAT in WAT (Figure 5g). This finding is important since it
blots, with the exception for the ucp1 blot. Here, the WAT blot is supports the idea that Foxc2 can act as a metabolicexposed 40 times longer than the BAT blot. Full names of probes
regulator by sensing the energy content of the diet and,used are found in the corresponding text section. Twelve micro-
in response to this, alter metabolic efficiency (Figuresgrams of total RNA/lane, GAPDH as an internal control.
3o and 7b).
as compared with wt at 0, 5, 20, 50, and 75 min (p 
Increased Sensitivity of the -Adrenergic/cAMP/0.001; Figure 3k). Insulin levels are dramatically lowered
Protein Kinase A Pathwayin tg mice at all time points (p  0.001; Figure 3l). It is
Induction of the cAMP-regulated ucp1 in WAT, the hy-quite extraordinary that tg mice on a high fat diet retain
pertrophy of BAT, the decrease of intraabdominal WATa plasma insulin profile almost identical to that observed
depots, and the upregulation of mRNAs encoding -ARswhen on a standard diet, while wt mice display almost
suggest that an increased sensitivity in the -adrener-a 3-fold increase in insulin plasma levels (Figures 3j and
gic/cAMP/protein kinase A (PKA) signaling pathway may3l). Wt mice exhibit a clear increase in glucose levels,
contribute to the phenotype of FOXC2 tg mice. In cotrans-while tg mice show a much more modest increase in
fection experiments, using 3T3-L1 adipocytes, we showglucose values (Figures 3i and 3k). These findings high-
that FOXC2 increases reporter gene activity of a con-light FOXC2, not only as a gene of importance for adi-
struct driven by the promoter of the RI gene (encodespose tissue distribution, morphology, and gene expres-
the regulatory subunit I of PKA; Figure 6a), whereas nosion profile, but also, more importantly, as a major
such regulation could be observed for the RII promoterregulator of general lipid and glucose metabolism, in-
(not shown). We also demonstrate increased RI mRNAcluding protection against diet-induced insulin resis-
levels in adipose tissue from tg mice (Figure 6a, insert)tance. They also support the lipotoxicity hypothesis, in
in a dose dependent manner with regard to transgenethat leanness and low levels of FFA are present in the
expression (Figure 4a). This is accompanied by elevatedmice (tg) that display the most insulin sensitive phe-
notype. levels of RI protein in WAT and BAT (Figure 6b). Basal
Cell
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Figure 6. Altered -Adrenergic Sensitivity, PKA Isozyme Composi-
tion, and Activation Kinetics in Adipose Tissue from FOXC2 tg-A
Mice
(a) Left: CAT reporter activity directed from the RI promoter trans-
fected together with FOXC2 expression vector or control vector into
3T3-L1 preadipocytes. Data (n  3 experiments) are CAT values
normalized for transfection efficiency, expressed as fold induction.
Right: RI and GAPDH mRNA levels in WAT from wt and the three
founder lines (A, B, and C) overexpressing FOXC2. (b) Levels of RI
and RII immunoreactive protein in WAT and BAT from tg animals
(n  4) compared to wt littermates (expressed relative to wt levels).
(c) Kinase activities using Kemptide as substrate in the presence
(total, open bars) or absence (free, solid bars) of 5 M cAMP. Activi-
ties in tg WAT and BAT (n  4) are shown relative to those in wt
Figure 5. Electron Microscopy and Oxygen Consumption, on littermates. (d) Kinase activities toward Kemptide measured in WAT
4-Month-Old FOXC2 tg-A Mice (b and d) and wt Littermates (a and homogenates from tg and wt littermate mice incubated with increas-
c) as Controls ing concentrations of cAMP. Total cAMP-inducible activity was set
(a and b) Scanning electron microscopy of intraabdominal WAT to 100%. Right panel, immunoblot demonstrating WAT levels of
from wt and tg mice, respectively. (c and d) Transmission electron RI and RII. Intracellular cAMP levels in adipocyte suspensions
microscopy of intraabdominal WAT. The apparent difference in size prepared from WAT of tg animals and wt littermates (each pooled
of the nuclei is due to the relative level of the sections used. The from 3 animals) and stimulated with either (e) a nonselective
finding of more and larger mitochondria in tg WAT is not influenced -agonist (isoproterenol, 1 M) or (f) a 3-selective agonist (CGP-
by the level of the section used. Scale bars in (a) and (b) equal 50 12177A,1 M). Equal amounts of cells were withdrawn at different
m and scale bars in (c) and (d) equal 1 m. The diameters of time points (0 to 10 min), in duplicates, mixed with stop buffer, and
adipocytes were measured (e) on images generated by electron flash-frozen. Values are means  SEM.
microscopy (n 10). Values are means SEM. (f) Oxygen consump-
tion of isolated tissue pieces of white and brown adipose tissue
were measured (see “Experimental Procedures”). Values are means 
and total PKA activity is decreased in tg WAT and BATSEM, n  4 in each group, and reflect the same number of adipo-
(Figure 6c). This may be due to an increased sensitivitycytes. They were counted after collagenase treatment (see “Experi-
mental Procedures”). In (g), the relative level of Foxc2 mRNA in wt to activation by cAMP, dissociation, and thereby degra-
(	/	) and heterozygous (	/
) mice on a standard diet (S) as well dation of PKA holoenzyme (Tasken et al., 1993). The
as 	/	 mice on a high fat diet (H) was measured using a real time PKA type I holoenzyme (RI2C2) binds cAMP with higher
quantitative PCR assay (see “Experimental Procedures”). These affinity and activates more easily than the PKA typemice had been on a high fat diet for approximately 12 weeks. Values
II enzyme (RII2C2) (Dostmann et al., 1990), normallyare means  SEM, n  4 in each group. (h) Weight of interscapular
expressed in WAT and BAT (Cummings et al., 1996;BAT as % of total body weight in mice six weeks of age; wt (	/	)
and Foxc2 	/
 littermates. Values are means  SEM, n  4 in each Dostmann et al., 1990). Indeed, PKA from WAT of FOXC2
group. tg mice with elevated protein levels of RI (Figure 6d,
insert) activates more easily than PKA from WAT of non-
tg littermates. A typical experiment is shown (Figure 6d),
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with Kact of 140 and 250 nM, respectively. The protein as well as for a selctive 3-agonist (Figures 6e and 6f)
as well as altered PKA holoenzyme composition (Figureslevels of RII appear unchanged (Figure 6d, insert). In
6a–6d). An alternative explanation to our findings wouldanother experiment, we showed that Kact for tg (n  4)
be a PGC1-induced increase of PPAR which, together,and wt (n  3) WAT is 116  9 and 233  9 (SEM;
would activate ucp1 (Figure 4b) (Puigserver et al., 1998).p  0.05), respectively. Thus, adipocytes from FOXC2
An increased intracellular level of FFA, as suggested bytg mice will have a lower threshold for PKA activation
the observed induction of HSL (Figure 4b), would pro-by adrenergic stimuli as compared with wt littermates
vide PPAR with endogenous ligand. This explanationdue to a PKA isozyme switch. This is in accordance
gains support from the finding that ectopic expressionwith what has been reported for mice with targeted
of PGC1 in white adipose cells, in vitro, activates expres-disruption of the RII gene (Cummings et al., 1996).
sion of ucp1 (Puigserver et al., 1998). As opposed toStimulation of wt adipocytes with a nonselective -ago-
our in vivo findings, these authors demonstrate a reduc-nist leads to 4- to 5-fold increase in cAMP levels at 1
tion in steady-state levels of aP2 mRNA. Nevertheless,min and a rapid termination of the signal. Stimulation of
it is possible that an increased adrenergic sensitivity,tg adipocytes leads to a strong (10-fold), prolonged,
on several levels, in conjunction with PGC1, PPAR, andand sustained increase in cAMP levels, which are not
PPAR activation (Figure 4b) contributes to induce aterminated at 10 min (Figure 6e). 3-agonist stimulation
WAT phenotype that will lead to dissipation of energyof adipocytes prepared from tg WAT displays a distinct
through an increased -oxidation and uncoupling. Thisincrease (4-fold) in cAMP levels with elevated levels over
is supported by the observations that adipocytes of10 min (Figure 6f). In contrast, little or no 3-agonist
transgenic origin contain more and larger mitochondriaresponse is observed in adipocytes from wt WAT. These
(Figures 5c and 5d) and that the oxygen consumptionobservations are in agreement with the strong upregula-
is significantly elevated in such adipocytes (Figure 5f).tion of 1-2-AR and the induction of 3-AR (which is virtu-
We speculate that increased mRNA levels for IR, IRS1,ally absent in wt) in tg WAT (Figure 4b) and indicate that
IRS2, and GLUT4 (Figure 4b) would lead to enlargedthe sensitivity of -adrenergic/cAMP/PKA pathway in
WAT depots with increased insulin sensitivity, as seenWAT from FOXC2 tg mice is increased at several levels.
in the aP2-GLUT4 mice (Shepherd et al., 1993). In FOXC2
tg mice, the imminent threat of obesity and insulin resis-Discussion
tance, due to activation of genes that stimulate adipo-
cyte differentiation (C/EBP, PPAR, and ADD1/SREBP1)From the data presented here, it is clear that FOXC2
and lipid accumulation (aP2 and adipsin), is counter-regulates, directly or indirectly, several aspects of adipo-
acted by factors that enhance energy dissipation (ucp1cyte metabolism. Even though it is likely that other path-
and pgc1). Thus, the FOXC2 tg mice would have beenways/genes are involved, the induction of ucp1 in WAT,
obese and insulin sensitive had it not been for the in-the hypertrophy of BAT, the decrease of intraabdominal
creased BAT and induction of ucp1 in WAT, which willWAT depots, the upregulation of mRNAs encoding
supply means by which energy can be dissipated. The
-adrenergic receptors, and the increased oxygen con-
mRNA levels for ucp1, 2-3-AR, C/EBP, RI, adipsin,sumption in tg WAT suggest that an increased sensitivity
IRS1, and GLUT4 all demonstrate a dose-response rela-
in a -adrenergic/cAMP/protein kinase A (PKA) path-
tion with regard to expression of the transgene (Figures
way, at least in part, can explain the phenotype of mice
4b and 6a), which could reflect a direct regulation by
overexpressing FOXC2. The finding of an isoenzyme FOXC2 (Figure 7a), whereas indirect effects could be
shift that will lower the threshold for PKA activation involved in regulation of the other genes (Figure 4b). It
by adrenergic stimuli and the increased sensitivity for is possible that FOXC2 directly, through transcriptional
-adrenergic agonists, in adipocytes from tg mice, pro- activation of “master” genes, controls a network that
vides further support for this hypothesis (Figures 6a–6d). regulates energy turnover (ucp1, 2-3-AR, and RI), dif-
Indeed, animals subjected to chronic adrenergic stimu- ferentiation (C/EBP), metabolism (adipsin), and insulin
lation show increased BAT depots and decreased WAT sensitivity (IRS1 and GLUT4) in adipocytes (Figure 7a). It
stores with multilocular BAT-like cells (Himms-Hagen et is interesting to note the almost complete concordance
al., 1994). The effects of chronic adrenergic stimulation between the insulin and glucose profiles for tg mice,
can in part be derived from an increased BAT cell prolif- regardless of diet (Figures 3i–3l), whereas wt mice de-
eration, ucp1 induction, and stimulation of lipolysis. This velop a pronounced insulin resistance when fed a high
will lead to loss of body fat, increased glucose tolerance, fat diet (Figures 3k and 3l). Thus, it is possible that
and decreased serum triglycerides, through a process factors that enhance energy dissipation can sense the
that mimics BAT adaptive thermogenesis (Lowell and metabolic status of the animal. The upregulation of
Flier, 1997; Yoshida et al., 1994). While the phenotype Foxc2 mRNA levels in animals on a high fat diet supports
in animals under chronic adrenergic stimulation, can, in this view (Figure 5g)
large part, be attributed to an increased energy turnover Thrifty genes are thought to conserve energy during
mediated through cell surface located -ARs, the meta- periods of famine whereas they constitute a risk for
bolic changes seen in FOXC2 tg mice are due to an developing obesity related conditions, e.g., type 2 dia-
increased expression level of an intracellular transcrip- betes, when energy is abundant. It has been speculated
tion factor that exerts a pleiotropic effect on gene ex- that there exists a balance between factors that con-
pression in BAT and WAT. The sensitivity of the -adren- serve—“thrifty” genes—and factors that mobilize en-
ergic-cAMP-protein kinase A (PKA) pathway is enhanced, ergy—“anti-thrifty”—genes. This balance allows sur-
in adipocytes, on several levels, as indicated by the vival during periods of food deprivation, frequently
encountered during evolution, without the maladaptiveincreased sensitivity for both a nonselective -agonist
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more, tg mice appear to be able to regulate energy
efficiency when fed a high fat diet, as demonstrated by
the reduced weight gain to food consumed ratio (Figure
3o). In this sense, FOXC2 could be regarded as an “anti-
thrifty” gene. This is further supported by the findings
that FOXC2 tg mice demonstrate a relative resistance
to diet-induced weight gain (Figure 3m) as well as diet-
induced insulin resistance (Figures 3k and 3l). One possi-
ble mechanism by which this could be achieved is
through the FOXC2-induced upregulation of mRNA lev-
els for HSL in WAT (Figure 4b), which could provide
means for an increased flow of FFA to the mitochondria,
where ucp1 would dissipate its energy content. An in-
crease in number and/or biological activity of mitochon-
dria, as reflected by increased levels of coxII and pgc1
(Figure 4b), would further enhance this process. The
relevance of this hypothesis is underscored by the fact
that tg WAT contains more and larger mitochondria (Fig-
ures 5c and 5d) and has an increased oxygen consump-
tion (Figure 5f).
Why is it that FOXC2 tg mice do not increase their
food intake to a level that would compensate for the
loss of adipose tissue? One explanation could be that
increased FOXC2 expression affects satiety signaling
to CNS. It has been speculated that BAT produces an
appetite suppressing signal since BAT-ablated mice are
hyperphagic (Flier, 1995). This would mean that although
FOXC2 tg mice do not eat more than their wild-type
littermates, they eat less than they would need to for
preservation of an energy store, comparable in size to
that of their wt littermates. This could be explained by
increased expression of a hypothetical appetite sup-
pressing signal from the enlarged BAT depot.
Based on the data reported here, FOXC2 should be
regarded as a candidate gene for obesity, insulin resis-
tance, and type 2 diabetes. The phenotype induced by
increasing FOXC2 expression in adipose tissue sup-Figure 7. Hypothetical Action of FOXC2 in an Adipocyte Gene Regu-
ports the hypothesis of lipotoxicity, since a decreaselatory Network
in total body lipid content and levels of FFA leads to(a) Filled arrows indicate known positive transcriptional regulation.
increased insulin sensitivity (Figures 3i–3l; Unger andOpen arrows represent a proposed action of FOXC2. ADD1/SREBP1
Orci, 2000; Boden, 1997). In this context, it is interestingboth activate transcription of acetyl CoA carboxylase (Lopez et al.,
1996), fatty acid synthase (FAS), and lipoprotein lipase (LPL) genes, to note that altering expression of a single gene in adi-
and increases the transcriptional activity of PPAR (Fajas et al., pose tissue results in systemic changes of glucose, insu-
1999). PPAR activates transcription of fatty acid transport protein lin, and lipid metabolism in a way that protects against
(FATP), acyl-CoA synthetase genes (Martin et al., 1997) (ACS), adipo- the consequences of caloric overload. We propose a
cyte fatty acid binding protein 422/aP2 (Tontonoz et al., 1994) (aP2),
model in which the degree of FOXC2 induction, in re-LPL (Schoonjans et al., 1996), and phosphoenolpyruvate carboxyki-
sponse to a caloric load, determines the efficiency bynase (Tontonoz et al., 1995) (PEPCK). C/EBP activates insulin-
which these calories are converted to triglycerides (Fig-responsive glucose transporter-4 (Kaestner et al., 1990) (GLUT4),
aP2(Christy et al., 1989), uncoupling protein-1 (Yubero et al., 1994) ure 7b). In this way, a pronounced FOXC2 induction will
(UCP1), the insulin receptor (IR), insulin receptor substrate-1 (Wu act as a defense against an increasing adipose tissue
et al., 1999b) (IRS1), and PEPCK (Park et al., 1990). A positive feed- mass. The degree of adrenergic sensitivity, regulated
back loop between C/EBP and PPAR has been suggested (Wu by FOXC2, could be regarded as a cellular “set point”et al., 1999b). (b) We propose that a strong induction of FOXC2 in
for metabolism in adipocytes. FOXC2 also constitutesresponse to a caloric load leads to a metabolic situation in which
novel drug target. Data presented here demonstrate thata large portion of the ingested calories would be dissipated as heat
FOXC2 is likely to play a role as a metabolic regulatorwhereas a weaker induction induces conservation of the caloric
load as triglycerides. and possibly a factor that can induce adaptive thermo-
genesis—with a potential capacity of counteracting not
only obesity, insulin resistance, hypertriglyceridemia, in-
creased plasma levels of FFA, and diet-induced insulinconsequences of an excess of adipose tissue in times
resistance, but also type 2 diabetes.when food is available (Flier, 1995; Friedman and Halaas,
1998; Zimmet and Alberti, 1997). Since the total body
Experimental Procedureslipid content in FOXC2 tg mice, on a standard diet, is
reduced from 30% to 10% (Figure 3c), without any signif- Cloning and DNA Construct
icant change in body weight or food consumption, there A human adipose tissue gt11 cDNA library (Clontech) was screened
with a probe mixture corresponding to the conserved forkhead do-must exist a net increase in energy expenditure. Further-
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main derived from FOXC1, FOXD1, FOXL1, and FOXA1. Hybridiza- GCCAACTCTCCTGAGAGCTT and 3 primer, CTCCTGCTTGAG
CTTCTGGTT (GenBank # AB017337). CoxII: 5 primer, CCATTCtion was carried out at low stringency, i.e., 6  SSC at 60C, posthy-
bridization washes at 0.5  SSC at 60C. One of the positive CAACTTGGTCTACAA and 3 primer, GGAACCA TTTCTAGGA
CAATG (GenBank # J01420). Adipsin: 5 primer, CGAGGCCGGATTrecombinants harboring a 2.1 kb insert was subcloned and se-
quenced. A 5.4 kb EcoRV-SmaI fragment was excised from pBluescript CTGGGTGGCCAG and 3 primer, TCGATCCACATCCGGTAGGATG
(GenBank # X04673). 1-AR: 5 primer, CGGCTGCAGACGCTCACII SK(	) vector containing the 5.4 kb promoter/enhancer of the
mouse aP2 gene and ligated into the EcoRV-SpeI blunt site of CAA and 3primer, CGCCACCAGTGCATGAGGAT (GenBank # L10084).
2-AR: 5 primer, GCTGCAG AAGA TAGACAAAT and 3 primer,pBluescript II SK(	) vector containing the 2.1 kb FOXC2 cDNA. A
7.6 kb XhoI blunt fragment containing the aP2 promoter/enhancer GGGATCCTCACACAGCAGTT (GenBank # X15643). 3-AR: 5
primer, CTGCTAGCATCGAGACCTT and 3 primer, CGAGCATAfollowed by the FOXC2 cDNA was excised from the above plasmid
and ligated into the EcoRV site of the pCB6	 vector, which contains GACGAAGAGCAT (GenBank # X60438). GLUT4: 5 primer,CTCAG
CAGCGAGTG ACTGGGAC and 3 primer, CCCTGAGTAGGCGCa polyadenylation signal from the human growth hormone gene.
After these procedures, the resulting 8.2 kb fragment, harboring the CAATGAGG (GenBank # D28561). IR: 5 primer, GTAGCCTGATC
ATCAACATCCG and 3 primer, CCTGCCCATCAAACTCTGTCACaP2-FOXC2 construct with polyadenylation signal, was flanked by
the unique sites NotI and AgeI. The plasmid was sequenced over (GenBank # J05149). IRS1: 5 primer, ATGGCGAGCCCTCCGGA
TACCG and 3 primer, CCTCTCCAACGCCAGAAGCTGCC (GenBankligation sites.
# X69722). IRS2: 5 primer, GGATAATGGTGACTATACCGAGA and
3 primer, CTCACATCGATGGCGATATAGTT (GenBank # AF090738).Transgenic Mice
PPAR: 5 primer, TCCCTTGTAGCCTTTTGTCAT and 3 primer,Construct DNA (aP2-FOXC2), purified using Qiagen kit, according
AAGCCATTGCCGTACGCGAT (GenBank # X75293). All other probesto manufacturer’s instructions, was injected into the male pronu-
used have been provided by researchers mentioned under “Ac-cleus of (C57BL/6J x CBA) F1 zygotes, cultured overnight and trans-
knowledgments.” cDNA probes were radiolabeled with [-32P]dCTPferred to pseudopregnant females. Tg founder lines were back-
(3000 Ci/mmol) by the random labeling method. Total RNA from micecrossed to C57BL/6J for four generations. Mice were feed a
in each group was pooled, and aliquots of 12 g were separated onstandard chow with 4% (w/w) fat content. In experiments with high
an agarose gel. The filters were hybridized with 32P-labeled probefat diet, mice were fed a chow with 35.9% (w/w) fat (Research Diets)
(106 cpm/ml) for 1 hr at 62C with QuikHyb solution (Stratagene) andfor 9 weeks. In the glucose tolerance experiment (Figure 3), mice
washed with 0.1% SDS/0.1SSC at 62C for 3 20 min. Adipocyteswere on their respective diets for 14 weeks. High fat chow has a
and stroma/vascular cells used in Figure 1c were isolated by colla-total energy content of 23.4 kJ/g, standard diet 12.6 kJ/g.
genase digestion (1mg/ml, Sigma C6885) in Dulbecco’s modified
Eagle’s medium at 37C for 60 min, followed by centrifugation (1500Histology
rpm 10 min), rendering the adipocytes floating at the top and theTissues were fixed overnight in 4% paraformaldehyde in PBS at
stroma/vascular fraction in the pellet. For analysis of Foxc2 mRNA4C, dehydrated, embedded in paraffin, sectioned (6–8 m), and
regulation (Figure 1d), 3T3-L1 cells were grown to confluence andstained with haematoxylin and eosin.
differentiated using a combination of dexametasone, insulin and,
metyl-isobutylxanthine for three days, followed by insulin alone for
Serum and Lipid Analysis
three days. Since the combination of agents used to induce differen-
Plasma insulin was determined radioimmunochemically with the use
tiation also increased Foxc2 mRNA (not shown), cells were contin-
of a guinea pig anti-rat insulin antibody, 125I-labeled porcine insulin
ued for four days without any stimulus to fully mature adipocytes
as tracer and rat insulin as standard (Linco). Free and bound radioac-
at day ten using standard protocols. At day eleven (five days after
tivity was separated by use of an anti-IgG (goat anti-guinea pig)
removal of the differentiation mixture), cells were treated with vari-
antibody (Linco). The sensitivity of the assay is 17 pmol/l and the
ous agents, subjected to Northern blotting and analysis of the Foxc2
coefficiency of variation is less than 3% at both low and high levels.
signal by -scintillation counting in a dot-matrix -plate counter
Plasma glucose was determined with the glucose oxidase method,
(Instant Imager, Packard).
and FFAs were measured photometrically. Plasma glucagon was
determined radioimmunochemically with the use of a guinea pig
Real-Time Quantitative RT-PCRantiglucagon antibody specific for pancreatic glucagon, 125I-labeled-
Reverse transcription of 1 g total RNA was carried out using a 1stglucagon as tracer, and glucagon standard (Linco). Free and bound
Strand cDNA Synthesis Kit for RT-PCR (AMV) (Roche, #1483188).radioactivity was separated by use of an anti-IgG (goat anti-guinea
0.25 l and 7.8 nl of the first strand cDNA synthesis were usedpig) antibody (Linco). The sensitivity of the assay is 7.5 pg/ml and
respectively per 50 l of PCR reaction (TaqMan Universal PCR Mas-the coefficient of variation is less than 9%. Blood levels of serum
ter Mix, Applied Biosystems) to determine Foxc2 and 18S ribosomalcholesterol and triglycerides were determined by standard, fully
RNA levels using the ABI Prism 7700 sequence detection system.enzymatic techniques. Total body lipid was assessed using alco-
The primer sequences used for Foxc2 detection were as follows.holic hydroxide digestion with saponification of all lipids and neutral-
Forward: 5-GAAAGCGCCCCTCTCTCAG-3 and reverse: 5-TGCization, followed by enzymatic determination of glycerol.
GGATAAGTTACCTGCGA-3; for 18S ribosome, forward: 5-AGTC
CCTGCCCTTTGTACACA-3  and reverse: 5-GATCCGAGGGIntravenous Glucose Tolerance Test
CCTCACTAAAC-3. The probe sequences for Foxc2 and 18S ribo-The mice were anesthetized with an intraperitoneal injection of midazo-
some were 5-6FAM-ACCAGGAGCAGAGAGC TCCGTGCAA-lam (0.4 mg/mouse) (Hoffman-La-Roche) and a combination of flua-
TAMRA-3 and 5-6FAM-CGCCC GTCGCTACTACCGATTGG-nison (0.9 mg/mouse) and fentanyl (0.02 mg/mouse) (Janssen).
TAMRA-3, respectively.Thereafter, a blood sample was taken from the retrobulbar, intraorbi-
tal, capillary plexus in heparinized tubes, whereafter D-glucose 1g/
Transfections and Reporter Gene Analysiskg (British Drug Houses) was injected rapidly intravenously. New
Nonconfluent cultures of 3T3-L1 adipocytes were transfected withblood samples were taken after 1, 5, 20, 50, and 75 min. Following
a CAT reporter (pCAT) driven by the human RI proximal promotersimmediate centrifugation at 4C, plasma was separated and stored
upstream of the alternatively spliced 1a and 1b leader exons (nucleo-at 
20C or until analysis.
tides 1509 to 2470 GenBank # Y07641). To control transfection
efficiency, a pGL3 control (Promega) luciferase-encoding vector wasNorthern Blot
used. In cotransfections, a FOXC2 expression vector or vector voidcDNA probes for mouse Foxc2, aP2, ADD-1/SREBP1, coxII, adipsin,
of insert was used. Transfections were carried out using lipofecta-1-3-AR, GLUT4, IR, IRS1, IRS2, and PPAR were prepared by RT-PCR
mine (Gibco), followed by CAT and luciferase assays.by use of first-strand cDNA from mouse epididymal fat poly(A)	 RNA.
The PCR primers used to generate these probes were as follows. Foxc2:
5 primer, GCTTCGCCTCCTCCATGGGAA and 3 primer, GGTTA Electron Microscopy
Tissue pieces for scanning electron microscopy were prepared withCAAATCCGCACTCGTT (GenBank # Y08222). aP2: 5 primer, CTCCTG
TGCTGCAGCCTTTCTC and 3 primer, CGTAACTCACCACCACC the OTOTO method, i.e., repeated cycles with 1% OsO4 in 0.1 M
cacodylate and a saturated solution of thiocarbhydrazide in water.AG CTTGTC (GenBank # M13261). A DD1/SRE BP1 : 5 primer,
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The samples were dehydrated in ethanol and infiltrated with hexa- lenberg Foundation, Pharmacia & Upjohn, Inc., and a Junior Individual
Grant from The Swedish Foundation for Strategic Research to S.E.methyldisilazane. The dried samples were mounted with carbon
adhesive tape on aluminum stubs and examined in a Zeiss 982
Gemini field emission scanning electron microscope without previ- Received March 1, 2001; revised August 2, 2001.
ous sputter coating. Tissue pieces for transmission electron micros-
copy were fixed with an aldehyde mixture of 2.5% glutaraldehyde
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